Fabrication of biocompatible porous scaffolds based on hydroxyapatite/collagen/chitosan composite for restoration of defected maxillofacial mandible bone
Open Access
- 29 May 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Progress in Biomaterials
- Vol. 8 (3), 137-154
- https://doi.org/10.1007/s40204-019-0113-x
Abstract
Fabrication of scaffolds from biomaterials for restoration of defected mandible bone has attained increased attention due to limited accessibility of natural bone for grafting. Hydroxyapatite (Ha), collagen type 1 (Col1) and chitosan (Cs) are widely used biomaterials which could be fabricated as a scaffold to overcome the paucity of bone substitutes. Here, rabbit Col1, shrimp Cs and bovine Ha were extracted and characterized with respect to physicochemical properties. Following the biocompatibility, degradability and cytotoxicity tests for Ha, Col1 and Cs a hydroxyapatite/collagen/chitosan (Ha·Col1·Cs) scaffold was fabricated using thermally induced phase separation technique. This scaffold was cross-linked with (1) either glutaraldehyde (GTA), (2) de-hydrothermal treatment (DTH), (3) irradiation (IR) and (4) 2-hydroxyethyl methacrylate (HEMA), resulting in four independent types (Ha·Col1·Cs-GTA, Ha·Col1·Cs-IR, Ha·Col1·Cs-DTH and Ha·Col1·Cs-HEMA). The developed composite scaffolds were porous with 3D interconnected fiber microstructure. However, Ha·Col1·Cs-IR and Ha·Col1·Cs-GTA showed better hydrophilicity and biodegradability. All four scaffolds showed desirable blood biocompatibility without cytotoxicity for brine shrimp. In vitro studies in the presence of human amniotic fluid-derived mesenchymal stem cells revealed that Ha·Col1·Cs-IR and Ha·Col1·Cs-DHT scaffolds were non-cytotoxic and compatible for cell attachment, growth and mineralization. Further, grafting of Ha·Col1·Cs-IR and Ha·Col1·Cs-DHT was performed in a surgically created non-load-bearing rabbit maxillofacial mandible defect model. Histological and radiological observations indicated the restoration of defected bone. Ha·Col1·Cs-IR and Ha·Col1·Cs-DHT could be used as an alternative treatment in bone defects and may contribute to further development of scaffolds for bone tissue engineering.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst (DAAD-91607303)
- International Atomic Energy Agency (CRP-No. 18343/R1)
This publication has 72 references indexed in Scilit:
- Infectious Disease Transmission during Organ and Tissue TransplantationEmerging Infectious Diseases, 2012
- Collagen Cross-Linking: Current Status and Future DirectionsJournal of Ophthalmology, 2012
- Study on Genipin: A New Alternative Natural Crosslinking Agent for Fixing Heterograft TissueThe Korean Journal of Thoracic and Cardiovascular Surgery, 2011
- Biomaterials & scaffolds for tissue engineeringMaterials Today, 2011
- Genipin‐cross‐linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applicationsJournal of Biomedical Materials Research Part A, 2010
- ExtSym: a program to aid space-group determination from powder diffraction dataJournal of Applied Crystallography, 2008
- Enhanced cell attachment using a novel cell culture surface presenting functional domains from extracellular matrix proteinsCytotechnology, 2008
- Optimization of UV cross‐linking density for durable and nontoxic collagen GAG dermal substituteJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Collagen and Bone StrengthJournal of Bone and Mineral Research, 1999
- Collagen-based devices for soft tissue repairJournal of Biomedical Materials Research, 1996